研究成果|京都大学大学院医学研究科 腎臓内科学|論文・学会発表 研究成果(論文・学会発表)

  • HOME
  • 研究成果|京都大学大学院医学研究科 腎臓内科学|論文・学会発表

発表論文

英文

和文

発表論文(英文)

2021年

(3) Erina Ono, Akira Ishii, Yoshiaki Higashi, Natsuko Koita, Takashi Ayaki, Katsuya Tanigaki, Shunsuke Takayanagi, Naoya Kondo, Kaoru Sakai, Shuichiro Endo, Hideki Yokoi, Takeshi Matsubara, Sachiko Minamiguchi, Ichizo Nishino, Ryosuke Takahashi & Motoko Yanagita. 
“Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report”
BMC Nephrol. 2021 Feb 27;22(1):74. (Accepted: 18 February, 2021)

(2) Takako Saeki, Tasuku Nagasawa, Yoshifumi Ubara, Yoshinori Taniguchi, Motoko Yanagita, Shinichi Nishi, Michio Nagata, Yutaka Yamaguchi, Takao Saito, Hitoshi Nakashima, Mitsuhiro Kawano. 
“Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology”
Ann Rheum Dis. 2021 Feb 23:annrheumdis-2020-219510.doi: 10.1136/annrheumdis-2020-219510. (Accepted: 29 January, 2021)

(1) Tatsuhito Miyanaga, Keishi Mizuguchi, Satoshi Hara, Takeshi Zoshima, Dai Inoue, Ryo Nishioka, Ichiro Mizushima, Kiyoaki Ito, Hiroshi Fuji, Kazunori Yamada, Yuki Sato, Motoko Yanagita & Mitsuhiro Kawano. 
“Tertiary lymphoid tissue in early-stage IgG4-related tubulointerstitial nephritis incidentally detected with a tumor lesion of the ureteropelvic junction: a case report”
BMC Nephrol. 2021;22(1):34. (Accepted: 12 January, 2021)

2020年

(31) Atsuro Sawada, Shusuke Hiragi, Hiroshi Tamura, Rei Goto, Yoko Matsuyama, Kaoru Sakai, Hitomi Miyata, Motoko Yanagita, Tomohiro Kuroda, Osamu Ogawa, Takashi Kobayashi.
“Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires”
Transplant Proc. 2021;53(3):881-884. (Available online: Dec 7, 2020)

(30) Shota Ozawa, Masaya Matsubayashi, Hitoki Nanaura, Motoko Yanagita, Kiyoshi Mori, Katsuhiko Asanuma, Nobuyuki Kajiwara, Kazuyuki Hayashi, Hiroshi Ohashi, Masato Kasahara, Hideki Yokoi, Hiroaki Kataoka, Eiichiro Mori, Takahiko Nakagawa.
“Proteolytic Cleavage of Podocin by Matriptase Exacerbates Podocyte Injury”
J Biol Chem. 2020;295(47):16002-16012. (Published: Nov 20, 2020)

(30) Shin-ichi Makino, Naritoshi Shirata, Juan Alejandro Oliva Trejo, Kanae Yamamoto-Nonaka, Hiroyuki Yamada, Takafumi Miyake, Kiyoshi Mori, Takahiko Nakagawa, Yoshitaka Tashiro, Hirofumi Yamashita, Motoko Yanagita, Ryosuke Takahashi and Katsuhiko Asanuma. 
“Impairment of Proteasome Function in Podocytes Leads to CKD”
J Am Soc Nephrol. 2021;32(3):597-613. (Accepted: Nov 20, 2020)

(29) Takako Saeki, Mitsuhiro Kawano, Tasuku Nagasawa, Yoshifumi Ubara, Yoshinori Taniguchi, Motoko Yanagita, Shinichi Nishi, Michio Nagata, Satoshi Hisano, Yutaka Yamaguchi, Hideki Nomura, Takao Saito, Hitoshi Nakashima.
“Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, andproposal of a new 2020 version”
Clin Exp Nephrol. 2021;25(2):99-109. (Accepted: Nov 4, 2020)

(28) Tadashi Sofue, Naoki Nakagawa, Eiichiro Kanda, Hajime Nagasu, Kunihiro Matsushita, Masaomi Nangaku, Shoichi Maruyama, Takashi Wada, Yoshio Terada, Kunihiro Yamagata, Ichiei Narita, Motoko Yanagita, Hitoshi Sugiyama, Takashi Shigematsu, Takafumi Ito, Kouichi Tamura, Yoshitaka Isaka, Hirokazu Okada, Kazuhiko Tsuruya, Hitoshi Yokoyama, Naoki Nakashima, Hiromi Kataoka, Kazuhiko Ohe, Mihoko Okada, Naoki Kashihara.
“Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)”
PLoS One. 2020;15(10):e0240402. (Accepted: Sep 24, 2020)

(27) Yoshinao Ozaki, Hirotaka Imamaki, Aki Ikeda, Mitsuaki Oura, Shunsaku Nakagawa, Taro Funakoshi, Shigeki Kataoka, Yoshitaka Nishikawa, Takahiro Horimatsu, Atsushi Yonezawa, Takeshi Matsubara, Motoko Yanagita, Manabu Muto, Norihiko Watanabe.
“Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses”
Cancer Chemother Pharmacol. 2020;86(5):693-699. (Accepted: Sep 24, 2020)

(26) Hiroyuki Yamada, Naritoshi Shirata, Shinichi Makino, Takafumi Miyake, Juan Alejandro Oliva Trejo, Kanae Yamamoto-Nonaka, Mitsuhiro Kikyo, Maulana A. Empitu, Ika N. Kadariswantiningsih, Maiko Kimura, Koichiro Ichimura, Hideki Yokoi, Masashi Mukoyama, Akitsu Hotta, Katsuhiko Nishimori, Motoko Yanagita, Katsuhiko Asanuma.
“MAGI-2 orchestrates the localization of backbone proteins in the slit diaphragm of podocytes”
Kidney Int. 2021;99(2):382-395. (Accepted: Sep 10, 2020)

(25) Noriaki Sato, Masanori Kakuta, Takanori Hasegawa, Rui Yamaguchi, Eiichiro Uchino, Koichi Murashita, Shigeyuki Nakaji, Seiya Imoto, Motoko Yanagita, Yasushi Okuno.
“Metagenomic profiling of gut microbiome in early chronic kidney disease”
Nephrol Dial Transplant. 2020 Sep 1;gfaa172. (Published online: Sep 1, 2020)

(24) Shusuke Hiragi, Noriaki Sato, Eiichiro Uchino, Tomohiro Kuroda, Motoko Yanagita.
“Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data”
Hypertens Res. 2021;44(3):337-347. (Accepted: Aug 11, 2020)

(23) Shinya Yamamoto, Masamichi Yamamoto, Jin Nakamura, Akiko Mii, Shigenori Yamamoto, Masahiro Takahashi, Keiichi Kaneko, Eiichiro Uchino, Yuki Sato, Shingo Fukuma, Hiromi Imamura, Michiyuki Matsuda, Motoko Yanagita.
“Spatiotemporal ATP Dynamics during AKI Predict Renal Prognosis”
J Am Soc Nephrol. 2020;31(12):2855-2869. (Accepted: Aug 10, 2020)

(22) Koji Muro, Naohiro Toda, Shinya Yamamoto, Motoko Yanagita.
“The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia”
Intern Med. 2021;60(4):583-589. (Accepted: Aug 3, 2020)

(21) Kanna Shinkawa, Satomi Yoshida, Tomotsugu Seki, Motoko Yanagita, Koji Kawakami.
“Risk factors of venous thromboembolism in patients with nephrotic syndrome: a retrospective cohort study”
Nephrol Dial Transplant. 2020 Jul 13; gfaa134. (Accepted: 13 July 2020)

(20) Eiichiro Uchino, Kanata Suzuki, Noriaki Sato, Ryosuke Kojima, Yoshinori Tamada, Shusuke Hiragi, Hideki Yokoi, Nobuhiro Yugami, Sachiko Minamiguchi, Hironori Haga, Motoko Yanagita, Yasushi Okuno.
“Classification of glomerular pathological findings using deep learning and nephrologist–AI collective intelligence approach.”
Int J Med Inform. 2020 Jul 11;141:104231. (Accepted: July 6, 2020)

(19) Jolanta Małyszko, Aristotelis Bamias, Farhad R Danesh, Alicja Dębska-Ślizień, Maurizio Gallieni, Morie A Gertz, Jan T Kielstein, Petra Tesarova, Germaine Wong, Michael Cheung, David C Wheeler, Wolfgang C Winkelmayer, Camillo Porta, Conference Participants.
“KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer”
Kidney Int. 2020;98(6):1407-1418. (Accepted: July 2, 2020)

(18) Tadashi Sofue, Naoki Nakagawa, Eiichiro Kanda, Hajime Nagasu, Kunihiro Matsushita, Masaomi Nangaku, Shoichi Maruyama, Takashi Wada, Yoshio Terada, Kunihiro Yamagata, Ichiei Narita, Motoko Yanagita, Hitoshi Sugiyama, Takashi Shigematsu, Takafumi Ito, Kouichi Tamura, Yoshitaka Isaka, Hirokazu Okada, Kazuhiko Tsuruya, Hitoshi Yokoyama, Naoki Nakashima, Hiromi Kataoka, Kazuhiko Ohe, Mihoko Okada, Naoki Kashihara.
“Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)”
PLoS One. 2020;15(7):e0236132. (Accepted: June 29, 2020)

(17) Issei Tomita, Shinji Kume, Sho Sugahara, Norihisa Osawa, Kosuke Yamahara, Mako Yasuda-Yamahara, Naoko Takeda, Masami Chin-Kanasaki, Tatsuroh Kaneko, Eric Mayoux, Michael Mark, Motoko Yanagita, Hisakazu Ogita, Shin-Ichi Araki, Hiroshi Maegawa.
“SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition”
Cell Metab. 2020;32(3):404-419.e6. (Accepted: June 26, 2020)

(16) Jinwook Choi, Jong-Eun Park, Georgia Tsagkogeorga, Motoko Yanagita, Bon-Kyoung Koo, Namshik Han, Joo-Hyeon Lee.
“Inflammatory Signals Induce AT2 Cell-Derived Damage-Associated Transient Progenitors that Mediate Alveolar Regeneration”
Cell Stem Cell. 2020;27(3):366-382.e7. (Accpeted: June 23, 2020)

(15) Porta C, Bamias A, Danesh FR, Dębska-Ślizień A, Gallieni M, Gertz MA, Kielstein JT, Tesarova P, Wong G, Cheung M, Wheeler DC, Winkelmayer WC, Małyszko J; Conference Participants.
“KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer”
Kidney Int. 2020;98(5):1108-1119. (Accepted: June 10, 2020)

(14) Hiroyuki Arai, Motoko Yanagita.
“Janus-faced: molecular mechanisms and versatile nature of renal fibrosis”
Kidney360. 2020;10.34067/KID.0001972020. (Accepted: May 14, 2020)

(13) Takeshi Yamamoto, Yoshitsugu Takabatake, Satoshi Minami, Shinsuke Sakai, Ryuta Fujimura, Atsushi Takahashi, Tomoko Namba-Hamano, Jun Matsuda, Tomonori Kimura, Isao Matsui, Jun-Ya Kaimori, Hiroaki Takeda, Masatomo Takahashi, Yoshihiro Izumi, Takeshi Bamba, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Yoshitaka Isaka.
“Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux”
Autophagy. 2020;Jun 28:1-14. (Accepted: Apr 19, 2020)

(12) Naoki Nakagawa, Tadashi Sofue, Eiichiro Kanda, Hajime Nagasu, Kunihiro Matsushita, Masaomi Nangaku, Shoichi Maruyama, Takashi Wada, Yoshio Terada, Kunihiro Yamagata, Ichiei Narita, Motoko Yanagita, Hitoshi Sugiyama, Takashi Shigematsu, Takafumi Ito, Kouichi Tamura, Yoshitaka Isaka, Hirokazu Okada, Kazuhiko Tsuruya, Hitoshi Yokoyama, Naoki Nakashima, Hiromi Kataoka, Kazuhiko Ohe, Mihoko Okada, Naoki Kashihara.
“J-CKD-DB: a nationwide multicentre electronic health record-based chronic kidney disease database in Japan”
Sci Rep. 2020;10(1):7351. (Accepted: Apr 13, 2020)

(11) Daisuke Takada, Susumu Kunisawa, Takeshi Matsubara, Kiyohide Fushimi, Motoko Yanagita, Yuichi Imanaka.
“Developing and Validating a Multivariable Prediction Model for In-Hospital Mortality of Pneumonia With Advanced Chronic Kidney Disease Patients: A Retrospective Analysis Using a Nationwide Database in Japan”
Clin Exp Nephrol. 2020;24(8):715-724. (Accepted: Mar 25, 2020)

(10) Noriaki Sato, Masanori Kakuta, Eiichiro Uchino, Takanori Hasegawa, Ryosuke Kojima, Wataru Kobayashi, Kaori Sawada, Yoshihiro Tamura, Itoyo Tokuda, Seiya Imoto, Shigeyuki Nakaji, Koichi Murashita, Motoko Yanagita, Yasushi Okuno.
“The Relationship Between Cigarette Smoking and the Tongue Microbiome in an East Asian Population”
J Oral Microbiol. 2020;12(1):1742527. (Published online: Mar 25, 2020)

(9) Yurina Miyajima, N Kafi Ealey, Yasutaka Motomura, Miho Mochizuki, Natsuki Takeno, Motoko Yanagita, Aris N Economides, Manabu Nakayama, Haruhiko Koseki, Kazuyo Moro.
“Effects of BMP7 Produced by Group 2 Innate Lymphoid Cells on Adipogenesis”
Int Immunol. 2020;32(6):407-419. (Accepted: Mar 5, 2020)

(8) Yuki Sato, Masahiro Takahashi, Motoko Yanagita.
“Pathophysiology of AKI to CKD Progression”
Semin Nephrol. 2020;40(2):206-215. (Published online: Mar 1, 2020)

(7) Noriaki Sato, Masanori Kakuta, Takanori Hasegawa, Rui Yamaguchi, Eiichiro Uchino, Wataru Kobayashi Kaori Sawada, Yoshihiro Tamura, Itoyo Tokuda, Koichi Murashita, Shigeyuki Nakaji, Seiya Imoto, Motoko Yanagita, and Yasushi Okuno.
“Metagenomic analysis of bacterial species in tongue microbiome of current and never smokers”
NPJ Biofilms Microbiomes. 2020;6(1):1. (Accepted: Feb 20, 2020)

(6) Yuki Sato, Peter Boor, Shingo Fukuma, Barbara M. Klinkhammer, Hironori Haga, Osamu Ogawa, Jürgen Floege, Motoko Yanagita.
“Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys”
Kidney Int. 2020;98(2):448-463. (Accepted: Feb 20, 2020)

(5) Kiyoharu Fukushima, Takashi Satoh, Fuminori Sugihara, Yuki Sato, Toru Okamoto, Sachiyo Yoshio, Songling Li, Satoshi Nojima, Daisuke Motooka, Shota Nakamura, Hiroshi Kida, Daron M. Standley, Eiichi Morii, Tatsuya Kanto, Motoko Yanagita, Yoshiharu Matsuura, Takashi Nagasawa, Atsushi Kumanogoh, and Shizuo Akira.
“Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhemotopoietic Cells Licenses the Development of Fibrosis”
Immunity. 2020;52(3):542-556.e13. (Accepted: Feb 19, 2020)

(4) Naofumi Kawahira, Daisuke Ohtsuka, Naoki Kida, Ken-ichi Hironaka, Yoshihiro Morishita.
“Quantitative Analysis of 3D Tissue Deformation Reveals Key Cellular Mechanism Associated with Initial Heart Looping”
Cell Rep. 2020;30(11):P3889–3903. (Accepted: Feb 18, 2020)

(3) Yusuke Hata, Takashige Kuwabara, Kiyoshi Mori, Youngna Kan, Yuki Sato, Shuro Umemoto, Daisuke Fujimoto, Tomoko Kanki, Yoshihiko Nishiguchi, Hideki Yokoi, Yutaka Kakizoe, Yuichiro Izumi, Motoko Yanagita, Masashi Mukoyama.
“Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic serum-induced glomerulonephritis by intraglomerular crosstalk”
Sci Rep. 2020;10(1):3056. (Accepted: Feb 3, 2020)

(2) Ryuta Fujimura, Takeshi Yamamoto, Yoshitsugu Takabatake, Atsushi Takahashi, Tomoko Namba-Hamano, Satoshi Minami, Shinsuke Sakai, Jun Matsuda, Atsushi Hesaka, Hiroaki Yonishi, Jun Nakamura, Isao Matsui, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Yoshitaka Isaka.
“Autophagy protects kidney from phosphate-induced mitochondrial injury”
Biochem Biophys Res Commun. 2020;524(3):636-642. (Accepted: Jan 24, 2020)

(1) Shingo Fukuma, Tatsuyoshi Ikenoue, Sayaka Shimizu, Edward C.Norton, Rajiv Saran, Motoko Yanagita, Genta Kato, Takeo Nakayama, Shunichi Fukuhara, and on behalf of BiDANE:Big Data Analysis of Medical Care for the Older in Kyoto.
“Quality of Care in Chronic Kidney Disease and Incidence of End-Stage Renal Disease in Older Patients:A Cohort Study”
Med Care. 2020;58(7):625-631. (Online published: Jan 23, 2020)

2019年

(20) Jun Matsuda, Atsushi Takahashi, Yoshitsugu Takabatake, Shinsuke Sakai, Satoshi Minami, Takeshi Yamamoto, Ryuta Fujimura, Tomoko Namba-Hamano, Hiroaki Yonishi, Jun Nakamura, Tomonori Kimura, Jun-Ya Kaimori, Isao Matsui, Masatomo Takahashi, Motonao Nakao, Yoshihiro Izumi, Takeshi Bamba, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Tamotsu Yoshimori, Yoshitaka Isaka.
“Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells”
Autophagy. 2020;16(10):1889-1904. (Accepted: Dec 18, 2019)

(19) Daisuke Nakano, Kento Kitada, Ningning Wan, Yahua Zhang, Helge Wiig, Kittikulsuth Wararat, Motoko Yanagita, Syann Lee, Lin Jia, Jens M. Titze, Akira Nishiyama.
“Lipopolysaccharide induces filtrate leakage from renal tubular lumina into the interstitial space via a proximal tubular Toll-like receptor 4-dependent pathway and limits sensitivity to fluid therapy in mice”
Kidney Int. 2020;97(5):904-912. (Accepted: Nov 21, 2019)

(18) Shigeki Kataoka, Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Naoya Kondo, Takeshi Matsubara, Motoko Yanagita, Shigemi Matsumoto, Manabu Muto.
“Long-term survival and renal dysfunction in a patient with recurrent colorectal cancer treated with Bevacizumab”
Clin J Gastroenterol. 2020;13(3):316-319. (Accepted: Oct 24, 2019)

(17) Hiroshi Kinashi, Naohiro Toda, Ting Sun, Tri Q. Nguyen, Yasuhiro Suzuki, Takayuki Katsuno, Hideki Yokoi, Jan Aten, Masashi Mizuno,Shoichi Maruyama,Motoko Yanagita, Roel Goldschmeding,and Yasuhiko Ito.
“Connective tissue growth factor is correlated with peritoneal lymphangiogenesis”
Sci Rep. 2019;9(1):12175. (Accepted: Aug 7, 2019)

(16) Masamichi Yamamoto, Minsoo Kim, Hirohiko Imai, Yamato Itakura, Gen Ohtsuki.
“Microglia-triggered plasticity of intrinsic excitability modulates psychomotor behaviors in acute cerebellar inflammation”
Cell Rep. 2019;28(11):2923–2938. (Accepted: July 23, 2019)

(15) Yuki Sato, Motoko Yanagita.
“Immunology of the ageing kidney”
Nat Rev Nephrol. 2019;15(10):625–640. (Accepted: July 22, 2019)

(14) Toshihiro Magaribuchi, Takashi Kobayashi, Naoko Kamo, Toshimi Kaido, Kaoru Sakai, Yuki Teramoto, Katsuhiro Ito, Masashi Kubota, Hideaki Takada, Atsuro Sawada, Shusuke Akamatsu, Toshinari Yamasaki, Takahiro Inoue, Motoko Yanagita, Shinji Uemoto, Osamu Ogawa.
“Kidney Auto-Transplantation for Intraoperative Right Renal Artery Injury in a Single Kidney Patient: A Case Report”
Hinyokika Kiyo. 2019;65(11):455-458. (Accepted: July 1, 2019)

(13) Yuki Sato, Motoko Yanagita.
“Functional heterogeneity of resident fibroblasts in the kidney”
Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(8):468–478. (Accepted: June 28, 2019)

(12) Yuki Sato, Motoko Yanagita.
“The unprecedented era of aging”
Inflamm Regen. 2019;39:15. (Accepted: June 18, 2019)

(11) Masahiro Koizumi, Kohei Ueda, Fumio Niimura, Akira Nishiyama, Motoko Yanagita, Akihiko Saito, Ira Pastan, Toshiro Fujita, Masafumi Fukagawa, Taiji Matsusaka.
“Podocyte Injury Augments Intrarenal Angiotensin II Generation and Sodium Retention in a Megalin-Dependent Manner”
Hypertension. 2019;74(3):509-517. (Accepted: June 12, 2019)

(10) Yuya Ide, Takahiro Horie, Naritatsu Saito, Shin Watanabe, Chiharu Otani, Yui Miyasaka, Yasuhide Kuwabara, Tomohiro Nishino, Tetsushi Nakao, Masataka Nishiga, Hitoo Nishi, Yasuhiro Nakashima, Fumiko Nakazeki, Satoshi Koyama, Masahiro Kimura, Shuhei Tsuji, Randolph Ruiz Rodriguez, Sijia Xu, Tomohiro Yamasaki, Toshimitsu Watanabe, Masamichi Yamamoto, Motoko Yanagita, Takeshi Kimura, Akira Kakizuka, and Koh Ono.
“Cardioprotective Effects of VCP Modulator KUS121 in Murine and Porcine Models of Myocardial Infarction”
JACC Basic Transl Sci. 2019;4(6):701-714. (Accepted: June 12, 2019)

(9) Song Ho Chang, Daisuke Mori, Hiroshi Kobayashi, Yoshifumi Mori, Hideki Nakamoto, Keita Okada, Yuki Taniguchi, Shurei Sugita, Fumiko Yano, Ung-il Chung, Joo-ri Kim-Kaneyama, Motoko Yanagita, Aris Ecomomides, Ernesto Canalis, Di Chen, Sakae Tanaka, Taku Saito.
“Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway”
Nat Commun. 2019;10(1):1442. (Accepted: Mar 14, 2019)

(8) Sho Sugahara, Shinji Kume, Masami Chin-Kanasaki, Issei Tomita, Makoto Yasuda-Yamahara, Kosuke Yamahara, Naoko Takeda, Norihisa Osawa, Motoko Yanagita, Shin-ichi Araki and Hiroshi Maegawa.
“Protein O-GlcNAcylation Is Essential for the Maintenance of Renal Energy Homeostasis and Function via Lipolysis during Fasting and Diabetes”
J Am Soc Nephrol. 2019;30(6):962-978. (Accepted: Mar 9, 2019)

(7) Shinsuke Sakai, Takeshi Yamamoto, Yoshitsugu Takabatake, Atsushi Takahashi, Tomoko Namba-Hamano, Satoshi Minami, Ryuta Fujimura, Hiroaki Yonishi, Jun Matsuda, Atsushi Hesaka, Isao Matsui, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita and Yoshitaka Isaka.
“Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes”
J Am Soc Nephrol. 2019;30(6):929-945. (Accepted: Feb 22, 2019)

(6) Maki Shinzawa, Shiro Tanaka, Hironobu Tokumasu, Daisuke Takada, Tatsuo Tsukamoto, Motoko Yanagita, Koji Kawakami.
“Association of Low Birth Weight With Childhood Proteinuria at Age 3 Years: A Population-Based Retrospective Cohort Study”
Am J Kidney Dis. 2019;74(1):141-143. (Accepted: Feb 20, 2019)

(5) Koji Muro, Takashi Kobayashi, Motoko Yanagita.
“The cortical rim sign in graft renal infarction”
Clin Exp Nephrol. 2019;23(9):1169–1170. (Accepted: 06 June 2019)

(4) Takaya Handa, Hiroyuki Suzuki, Hiroyuki Matsubara, Hiroaki Terajima and Tatsuo Tsukamoto.
“Unusual communication of an embedded peritoneal dialysis catheter with the colon before use: a case report with literature review”
Ren Replace Ther. 2019;5(1):1. (Accepted: Apr 29, 2019)

(3) Zhengtao Qin, Carl K. Hoh, Emilia S. Olson, Amin Haghighat Jahromi, David J. Hall, Christopher V. Barback, Young-Hyun You, Motoko Yanagita, Kumar Sharma, and David R. Vera.
“Molecular imaging of the glomerulus via mesangial cell uptake of radiolabeled tilmanocept”
J Nucl Med. 2019;60(9):1325-1332. (Accepted: Jan 24, 2019)

(2) Hiroyuki Yamada, Kent Doi, Tatsuo Tsukamoto, Hideyasu Kiyomoto, Kazuto Yamashita, Motoko Yanagita, Yoshio Terada, Kiyoshi Mori.
“Low-dose atrial atriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis”
Crit Care. 2019;23(1):41. (Accepted: Jan 22, 2019)

(1) Shusuke Hiragi, Rei Goto, Yukari Tanaka, Yoko Matsuyama, Atsuro Sawada, Kaoru Sakai, Hitomi Miyata, Hiroshi Tamura, Motoko Yanagita, Tomohiro Kuroda, Osamu Ogawa, Takashi Kobayashi.
“Estimating the Net Utility Gains Among Donors and Recipients of Adult Living Donor Kidney Transplant”
Transplant Proc. 2019;51(3):676–683. (Accepted: Jan 17, 2019)

2018年

(18) Keita Hirano, Daiki Kobayashi, Naoto Kohtani, Yukari Uemura, Yasuo Ohashi, Yasuhiro Komatsu, Motoko Yanagita, Akira Hishida.
“Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study”
Clin Exp Nephrol. 2019;23(5):613-620. (Accepted: Dec 10, 2018)

(17) Long Tan, Noriaki Sato, Atsuko Shiraki, Motoko Yanagita, Yoshihiro Yoshida, Yoshinori Takemura, Kimiyasu Shiraki.
“Everolimus delayed and suppressed cytomegalovirus DNA synthesis, spread of the infection”
Antiviral Res. 2019;162:30-38 (Accepted: Dec 7, 2018)

(16) Naoya Toriu, Toshiharu Ueno, Hiroki Mizuno, Akinari Sekine, Noriko Hayami, Rikako Hiramatsu, Keiichi Sumida, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe,Junichi Hoshino, Naoki Sawa, Kenmei Takaichi, Takeshi Fujii, Tomoka Hasegawa,Norio Amizuka, Motoko Yanagita, Yoshifumi Ubara.
“Brown tumor diagnosed three years after parathyroidectomy in a patient with nail-patella syndrome: A case report”
Bone Rep. 2018;10:100187. (Accepted: Dec 5, 2018)

(15) Erina Ono, Eiichiro Uchino, Keita P. Mori, Hideki Yokoi, Naohiro Toda, Kenichi Koga, Masato Kasahara, Takeshi Matsubara, Motoko Yanagita.
“Peritonitis due to Mycobacterium abscessus in peritoneal dialysis patients: case presentation and mini-review”
Ren Replace Ther. 2018;4:52. (Accepted: Nov 19, 2018)

(14) Jin Nakamura, Yuki Sato, Yuichiro Kitai, Shuichi Wajima, Shinya Yamamoto, Akiko Oguchi, Ryo Yamada, Keiichi Kaneko, Makiko Kondo, Eiichiro Uchino, Junichi Tsuchida, Keita Hirano, Kumar Sharma, Kenji Kohno, Motoko Yanagita.
“Myofibroblasts acquire retinoic acid–producing ability during fibroblast-to-myofibroblast transition following kidney injury”
Kidney Int. 2019;95(3):526-539. (Accepted: Oct 4, 2018)

(13) Yuki Sato, Motoko Yanagita.
“Immune cells and inflammation in AKI to CKD progression”
Am J Physiol Renal Physiol. 2018;315(6):F1501–F1512. (Accepted: Aug 23, 2018)

(12) Shingo Fukuma, Miho Kimachi, Kenji Omae, Yuki Kataoka, Hajime Yamazaki, Manabu Muto,Tadao Akizawa, Motoko Yanagita, Shunichi Fukuhara.
“Dialysis physicians’ referral behaviors for hemodialysis patients suspected of having cancer:A vignette-based questionnaire study”
PLoS One. 2018;13(8): e0202322. (Accepted: Aug 1, 2018)

(11) Kent Doi, Osamu Nishida, Takashi Shigematsu, Tomohito Sadahiro, Noritomo Itami, Kunitoshi Iseki, Yukio Yuzawa, Hirokazu Okada, Daisuke Koya, Hideyasu Kiyomoto, Yugo Shibagaki, Kenichi Matsuda, Akihiko Kato, Terumasa Hayashi, Tomonari Ogawa, Tatsuo Tsukamoto, Eisei Noiri, Shigeo Negi, Koichi Kamei, Hirotsugu Kitayama, Naoki Kashihara, Toshiki Moriyama, Yoshio Terada, and The Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee.
“The Japanese Clinical Practice Guideline for acute kidney injury 2016”
Ren Replace Ther. 2018;4:36. (Accepted: June 22, 2018)

(10) Fumiko Nakazeki, Masataka Nishiga, Takahiro Horie, Hitoo Nishi, Yasuhiro Nakashima, Osamu Baba, Yasuhide Kuwabara, Tomohiro Nishino, Tetsushi Nakao, Yuya Ide, Satoshi Koyama, Masahiro Kimura, Shuhei Tsuji, Naoya Sowa, Shigeo Yoshida, Simon J. Conway, Motoko Yanagita, Takeshi Kimura, and Koh Ono.
“Loss of periostin ameliorates adipose tissue inflammation and fibrosis in vivo”
Sci Rep. 2018;8:8553. (Accepted: May 23, 2018)

(9) Naohiro Toda, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“CTGF in kidney fibrosis and glomerulonephritis”
Inflamm Regen. 2018;38:14. (Accepted: May 8, 2018)

(8) Naoya Toriu, Junichi Hoshino, Saeko Kobori, Sun Watanabe, Masahiko Oguro, Yoichi Oshima, Rikako Hiramatsu, Hiroki Mizuno, Daisuke Ikuma, Akinari Sekine, Noriko Hayami, Keiichi Sumida, Masayuki
Yamanouchi, Eiko Hasegawa, Naoki Sawa, Kenmei Takaichi, Motoko Yanagita, Takuya Fujimaru, Eisei Hohara, Shinichi Uchida, Yoshifumi Ubara.
“Transcatheter Arterial Embolization Therapy for Huge Renal Cysts: Two Case Reports”
Case Rep Nephrol Dial. 2018;8(1):82–89. (Accepted: Apr 9, 2018)

(7) Naoya Toriu, Hiroki Mizuno, Naoki Sawa, Keiichi Sumida, Tatsuya Suwabe, Noriko Hayami, Akinari Sekine, Masayuki Yamanouchi, Junichi Hoshino, Kenmei Takaichi, Motoko Yanagita, Takuya Fujimaru, Takayasu Mori, Eisei Sohara, Shinichi Uchida, Yoshifumi Ubara.
“Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter”
Case Rep Oncol. 2018;11(2):258–267. (Accepted: Mar 22, 2018)

(6) Hiroaki Kitamura, Daisuke Nakano, Yoshiharu Sawanobori, Takehiko Asaga, Hideki Yokoi, Motoko Yanagita, Masashi Mukoyama, Takeshi Tokudome, Kenji Kanagawa, Gotaro Shirakami, Akira Nishiyama.
“Guanylyl Cyclase A in Both Renal Proximal Tubular and Vascular Endothelial Cells Protects the Kidney against Acute Injury in Rodent Experimental Endotoxemia Models”
Anesthesiology. 2018;129(2):296-310. (Accepted: Mar 12, 2018)

(5) Rin Asao, Takuto Seki, Miyuki Takagi, Hiroyuki Yamada, Fumiko Kodama, Yoshiko Hosoe-Nagai, Eriko Tanaka, Juan Alejandro Oliva Trejo, Kanae Yamamoto-Nonaka, Yu Sasaki, Teruo Hidaka, Takashi Ueno, Motoko Yanagita, Yusuke Suzuki, Yasuhiko Tomino, Katsuhiko Asanuma.
“Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis”
Sci Rep. 2018;8(1):5061. (Accepted: Mar 6, 2018)

(4) Hiroyuki Arai, Naohiro Toda, Ryo Kamimatsuse, Keisuke Nishioka, Shuichiro Endo, Shinichi Akiyama, Shoichi Maruyama, Takeshi Matsubara, Hideki Yokoi, Motoko Yanagita.
“A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis”
Intern Med. 2018 Intern Med. 2018;57(19):2873–2877. (Accepted: Feb 18, 2018)

(3) Shusuke Hiragi, Hiroyuki Yamada, Tatsuo Tsukamoto, Kazuki Yoshida, Naoya Kondo, Takeshi Matsubara, Motoko Yanagita, Hiroshi Tamura, Tomohiro Kuroda.
“Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study”
Clin Epidemiol. 2018;10:265–276. (Accepted: Jan 24, 2018)

(2) Taku Iguchi, Koji Takaori, Akiko Mii, Yuki Sato, Yasunori Suzuki,
Hajime Yoshifuji, Hiroshi Seno, Osamu Ogawa, Koichi Omori, Kazuhisa Bessho, Satoru Kondo, Tomokazu Yoshizaki, Hitoshi Nakashima, Takao Saito, Tsuneyo Mimori, Hironori Haga, Mitsuhiro Kawano, Motoko Yanagita.
“Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease”
Mod Pathol. 2018;31(6):890–899. (Accepted: Jan 17, 2018)

(1) Eiichiro Uchino, Daisuke Takada, Haruta Mogami, Takeshi Matsubara, Tatsuo Tsukamoto, Motoko Yanagita.
“Membranous nephropathy associated with pregnancy: an anti-phospholipase A2 receptor antibody-positive case report”
CEN Case Rep. 2018;7(1):101–106. (Accepted: Jan 10, 2018)

2017年

(18) Naoya Toriu, Masayuki Yamanouchi, Rikako Hiramatsu, Noriko Hayami, Junichi Hoshino, Akinari Sekine, Masahiro Kawada, Eiko Hasegawa, Tatsuya Suwabe, Keiichi Sumida, Toshiharu Ueno, Naoki Sawa, Kenichi Ohashi, Takeshi Fujii, Kenmei Takaichi, Motoko Yanagita, Tetsuro Kobayasi, Yoshifumi Ubara.
“Preservation of renal function by intensive glycemic control”
Endocrinol Diabetes Metab Case Rep. 2018; 2018:17–0136. (Accepted: Dec 6, 2017)

(17) Naoya Toriu, Naoki Sawa, Masahiko Oguro, Hiroki Mizuno, Yoichi Oshima, Eiko Hasegawa, Keiichi Sumida, Tatsuya Suwabe, Masahiro Kawada, Toshiharu Ueno, Noriko Hayami, Akinari Sekine, Rikako Hiramatsu, Masayuki Yamanouchi, Junichi Hoshino, Kenmei Takaichi, Kenichi Ohashi, Takeshi Fujii, Motoko Yanagita, Yoshifumi Ubara.
“Renal-limited cryoglobulinemic vasculitis: Two case reports”
Interm Med. 2018;57(13):1879–1886. (Accepted: Dec 5, 2017)

(16) Akira Ishii, Goro Katsuura, Hirotaka Imamaki, Hiroyuki Kimura, Keita P. Mori, Takashige Kuwabara, Masato Kasahara, Hideki Yokoi, Kousaku Ohinata, Tomoko Kawanishi, Junichi Tsuchida, Yuji Nakamoto, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama, Kiyoshi Mori.
“Obesity-promoting and anti-thermogenic effects of neutrophil gelatinase-associated lipocalin in mice”
Sci Rep. 2017;7(1):15501. (Accepted: Nov 1, 2017)

(15) Naohiro Toda, Kiyoshi Mori, Masato Kasahara, Kenichi Koga, Akira Ishii, Keita P.Mori, Keisuke Osaki, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation”
Nephrol Dial Transplant. 2018;33(6):943–953. (Accepted: October 9, 2017)

(14) Daisuke Takada, Tatsuo Tsukamoto, Miho Fuse, Shinpei Kada, Motoko Yanagita.
“The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: A case report”
BMC Nephrol. 2017;18(1):315. (Accepted: Sep 28, 2017)

(13) Shigeo Horie, Mototsugu Oya, Nangaku Masanori, Yoshinari Yasuda, Yasuhiro Komatsu, Motoko Yanagita, Yuko Kitagawa, Hiroyuki Kuwano, Hiroyuki Nishiyama, Chikashi Ishioka, Hiromasa Takaishi, Hideki Shimodaira, Akira Mogi, Yuichi Ando, Koji Matsumoto, Daiuske Kadowaki, Satoru Mutoa.
“Guidelines for treatment of renal injury during cancer chemotherapy 2016”
Clin Exp Nephrol. 2018;22(1):210-244. (Published: Aug 30, 2017)

(12) Hiroyuki Yamada, Munehiro Ito, Tatsuo Tsukamoto, Motoko Yanagita.
“Skin rash in a patient with antineutrophil cytoplasmic antibody vasculitis”
Kidney Int. 2017;92(1):269. (Published: July 1, 2017)

(11) Kohei Ikezoe, Tomohiro Handa, Kiminobu Tanizawa, Hideki Yokoi, Takeshi Kubo, Kensaku Aihara, Akihiko Sokai, Yoshinari Nakatsuka, Seishu Hashimoto, Kiyoshi Uemasu, Susumu Sato, Shigeo Muto, Sonoko Nagai, Motoko Yanagita, Kazuo Chin, Toyohiro Hirai, Yoshio Taguchi, Michiaki Mishima.
“Chonic Kidney Disease Predicts Survival in Patients with Idiopathic Pulmonary Fibrosis”
Respiration. 2017;94(4):346-354. (Accepted: June 13, 2017)

(10) Yuki Sato, Motoko Yanagita.
“Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation”
Inflamm Regen. 2017;37:17. (Accepted: May 9, 2017)

(9) Yoshinaga Okumura, Kanae Asai, Takashi Kobayashi, Hitomi Miyata, Yukari Tanaka, Yoshiyuki Okada, Kaoru Sakai, Tomomi Kamba, Hidemi Tsuji, Kenichiro Shide, Kazuaki Nagashima, Motoko Yanagita, Nobuya Inagaki, Osamu Ogawa, Hiromitsu Negoro.
“Dietary Sodium Restriction Reduces Nocturnal Urine Volume and Nocturnal Polyuria Index in Renal Allograft Recipients with Nocturnal Polyuria”
Urology. 2017;106:60-64. (Accepted: Apr 17, 2017)

(8) Naritoshi Shirata, Kan-ichiro Ihara, Kanae Yamamoto-Nonaka, Takuto Seki, Shin-ichi Makino, Juan Alejandro Oliva Trejo, Takafumi Miyake, Hiroyuki Yamada, Kirk Campbell, Takahiko Nakagawa, Kiyoshi Mori, Motoko Yanagita, Peter Mundel, Katsuhiko Nishimori, Katsuhiko Asanuma.
“Glomerulosclerosis Induced by deficiency of membrane-associated guanylate kinase inverted 2 in kidney podocytes”
J Am Soc Nephrol. 2017;28(9):2654–2669. (Accepted: Apr 3, 2017)

(7) Rio Noto, Nozomu Kamiura, Yuichiro Ono, Sumie Tabata, Shigeo Hara, Hideki Yokoi, Akihiro Yoshimoto, Motoko Yanagita.
“Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report”
BMC Nephrology. 2017;18(1):127. (Accepted: Mar 23, 2017)

(6) Yukiko Kato, Kiyoshi Mori, Masato Kasahara, Keisuke Osaki, Akira Ishii, Keita P. Mori, Naohiro Toda, Shoko Ohno, Takashige Kuwabara, Takeshi Tokudome, Ichiro Kishimoto, Moin A. Saleem, Matsusaka, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition”
Sci Rep. 2017;7:46624. (Accepted: Mar 22, 2017)

(5) Takeo Nakayama, Yuichi Imanaka, Yasushi Okuno, Genta Kato, Tomohiro Kuroda, Rei Goto, Shiro Tanaka, Hiroshi Tamura, Shunichi Fukuhara, Shingo Fukuma, Manabu Muto, Motoko Yanagita, Yosuke Yamamoto and on behalf of BiDAME: Big Data Analysis of Medical Care for the Elderly in Kyoto.
“Analysis of the evidence-practice gap to facilitate proper medical care for the elderly: investigation, using databases, of utilization measures for National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB)”
Environ Health Prev Med. 2017;22(1):51. (Accepted: Feb 1, 2017)

(4) Kandai Nozu, Shogo Minamikawa, Shiro Yamada, Masafumi Oka, Motoko Yanagita, Naoya Morisada, Shuichiro Fujinaga, China Nagano, Yoshimitsu Gotoh, Eihiko Takahashi, Takahiro Morishita, Tomohiko Yamamura, Takeshi Ninchoji, Hiroshi Kaito, Ichiro Morioka, Koichi Nakanishi, Igor Vorechovsky, Kazumoto Iijima.
“Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis”
J Hum Genet. 2017;62(7):733-735. (Accepted: Jan 31, 2017)

(3) Noriaki Sato, Hideki Yokoi, Hirotaka Imamaki, Eiichiro Uchino, Kaoru Sakai, Takeshi Matsubara, Tatsuo Tsukamoto, Sachiko Minamiguchi, Motoko Yanagita.
“Renal-limited vasculitis with elevated levels of multiple antibodies”
CEN Case Reports. 2017;6(1):79–84. (Accepted: Jan 18, 2017)

(2) Yoshitaka Nishikawa, Taro Funakoshi, Takahiro Horimatsu, Shinichi Miyamoto, Takeshi Matsubara, Motoko Yanagita, Shunsaku Nakagawa, Atsushi Yonezawa, Kazuo Matsubara, Manabu Muto.
“Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia”
Cancer Chemother Pharmacol. 2017;79(3):629-633. (Accepted: Jan 27, 2017)

(1) Naohiro Toda, Kiyoshi Mori, Masato Kasahara, Akira Ishii, Kenichi Koga, Keita P. Mori, Yukiko Kato, Takashige Kuwabara, Katsutoshi Kojima, Diasuke Taura, Masakatsu Sone, Taiji Matsusaka, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Hideki Yokoi.
“Crucial role of mesangial cell-derived connective tissue growth factor in a mouse model of anti-glomerular basement membrane glomerulonephritis”
Sci Rep. 2017;7:42114. (Accepted: Jan 6, 2017)

2016年

(22) Eiichiro Uchino, Naoya Kondo, Takeshi Matsubara, Motoko Yanagita.
“Automated electronic alert systems for acute kidney injury: Current status and future perspectives”
Contrib Nephrol. 2017;189:124–129. (Accepted: December 12, 2016)

(21) Mitchell H Rosner, Amaka Edeani, Motoko Yanagita, Ilya G. Glezerman, Nelson Leung.
“Paraprotein-related kidney disease: Diagnosing and treating monoclonal gammopathy of renal significance”
Clin J Am Soc Nephrol. 2016;11(12):2280–2287. (Published: Dec 7, 2016)

(20) Koji Kitagori, Hajime Yoshifuji, Takuma Oku, Chiyomi Sasaki, Hitomi Miyata, Keita P. Mori, Toshiki Nakajima, Koichiro Ohmura, Daisuke Kawabata, Naoichiro Yukawa, Yoshitaka Imura, Kosaku Murakami, Ran Nakashima, Takashi Usui, Takao Fujii, Kaoru Sakai, Motoko Yanagita, Yoshitaka Hirayama, Tsuneyo Mimori.
“Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis”
PLoS One. 2016;11(12):e0167141. (Accepted: Nov 9, 2016)

(19) Takeshi Yamamoto, Yoshitsugu Takabatake, Atsushi Takahashi, Tomonori Kimura, Tomoko Namba, Jun Matsuda, Satoshi Minami, Jun-ya Kaimori, Isao Matsui, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, and Yoshitaka Isaka.
“High-Fat Diet-Induced Lysosomal Dysfunction and Impaired Autophagic Flux Contribute to Lipotoxicity in the Kidney”
J Am Soc Néphrol. 2017;28(5):1534-1551. (Accepted: Nov 7, 2016)

(18) Maki Shinzawa, Shiro Tanaka, Hironobu Tokumasu, Daisuke Takada, Tatsuo Tsukamoto, Motoko Yanagita, Koji Kawakami.
“Maternal smoking during pregnancy, household smoking after the child’s birth, and childhood proteinuria at age 3 years”
Clin J Am Soc Nephrol. 2017;12(2):253–260. (Accepted: Oct 24, 2016)

(17) Koji Futatsugi, Hirobumi Tokuyama, Shinsuke Shibata, Makiko Naitoh, Takeshi Kanda, Hitoshi Minakuchi, Shintaro Yamaguchi, Koichi Hayashi, Yoji Andrew Minamishima, Motoko Yanagita, Shu Wakino, Hiroshi Itoh.
“Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules”
Sci Rep. 2016;6:36533. (Accepted: Oct 17, 2016)

(16) Taro Funakoshi, Takahiro Horimatsu, Michio Nakamura, Koichi Shiroshita, Koichi Suyama, Masashi Mukoyama, Takuro Mizukami, Tsutomu Sakurada, Kazuhiko Tsuruya, Akira Nozaki, Kensei Yahata, Yukinori Ozaki, Hisateru Yasui, Shingo Fukuma, Shunichi Fukuhara, Kazuo Matsubara, Naoya Kondo, Takeshi Matsubara, Motoko Yanagita, Manabu Muto.
“Chemotherapy in cancer patients undergoing hemodialysis: A multicenter study”
ESMO Open. 2018;3(2):e000301. (Published online: Oct 9, 2016)

(15) Hiroyuki Yamada, Tatsuo Tsukamoto, Hiromichi Narumiya, Kazumasa Oda, Satoshi Higaki, Ryoji Iizuka, Motoko Yanagita, Masako Deguchi.
“Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin-B direct hemoperfusion for septic shock patients: a retrospective cohort study”
J Intensive Care. 2016;4:64. (Accepted: Sep 15, 2016)

(14) Kanae Asai, Takashi Kobayashi, Hitomi Miyata, Yukari Tanaka, Yoshiyuki Okada, Kaoru Sakai, Hiromitsu Negoro, Tomomi Kamba, Hidemi Tsuji, Kenichiro Shide, Motoko Yanagita, Nobuya Inagaki, and Osamu Ogawa.
“The Short-Term Impact of Dietary Counseling on Sodium Intake and Blood Pressure in Renal Allograft Recipients”
Prog Transpl. 2016;26(4):365-371. (Published online: Aug 28, 2016)

(13) Yumiko Togo, Katsu Takahashi, Kazuyuki Saito, Honoka Kiso, Hiroko Tsukamoto, Boyen Huang, Motoko Yanagita, Manabu Sugai, Hidemitsu Harada, Toshihisa Komori, Akira Shimizu, Mary MacDougall, Kazuhisa Bessho.
“Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development”
PLoS One. 2016;11(8):e0161067. (Accepted: July 30, 2016)

(12) Takaori K, Yanagita M.
“Insights into the Mechanisms of the acute kidney injury-to-chronic kidney disease continuum”
Nephron. 2016;134:172–176. (Accepted: Jun 26, 2016)

(11) Yuki Sato, Akiko Mii, Yoko Hamazaki, Harumi Fujita, Hirosuke Nakata, Kyoko Masuda, Shingo Nishiyama, Shinsuke Shibuya, Hironori Haga, Osamu Ogawa, Akira Shimizu, Shuh Narumiya, Tsuneyasu Kaisho, Makoto Arita, Masashi Yanagisawa, Masayuki Miyasaka, Kumar Sharma, Nagahiro Minato, Hiroshi Kawamoto, Motoko Yanagita.
“Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney”
JCI Insight. 2016;1(11):e87680. (Accepted: Jun 13, 2016)

(10) Junichi Tsuchida, Taiji Matsusaka, Masato Ohtsuka, Hiromi Miura, Yukiko Okuno, Katsuhiko Asanuma, Takahiko Nakagawa, Motoko Yanagita, Kiyoshi Mori.
“Establishment of Nephrin Reporter Mice and Use for Chemical Screening”
PLoS One. 2016 Jun 30;11(6):e0157497. (Accepted: May 30, 2016)

(9) Keita P. Mori, Hideki Yokoi, Masato Kasahara, Hirotaka Imamaki, Akira Ishii, Takashige Kuwabara,
Kenichi Koga, Yukiko Kato, Naohiro Toda, Shoko Ohno, Koichiro Kuwahara, Tomomi Endo, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama, Kiyoshi Mori.
“Increase of total nephron albumin filtration and reabsorption in diabetic Nephropathy”
J Am Soc Nephrol. 2017;28:278–289. (Accepted: May 28, 2016)

(8) Shoko Ohno, Hideki Yokoi, Kiyoshi Mori, Masato Kasahara, Koichiro Kuwahara, Junji Fujikura, Masaki Naito, Takashige Kuwabara, Hirotaka Imamaki, Akira Ishii, Moin A. Saleem, Tomohiro Numeta, Yasuo Mori, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama.
“Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure”
Sci Rep. 2016;6:27192. (Accepted May 16, 2016)

(7) Haruomi Nishio, Tatsuo Tsukamoto, Takeshi Matsubara, Yoichiro Okada, Ryosuke Takahashi, Motoko Yanagita.
“Thrombotic Microangiopathy Caused by Interferon β-1b for Multiple Sclerosis: A Case Report”
CEN Case Rep. 2016;5(2):179-183. (Accepted: May 5, 2016)

(6) Shingo Fukuma, Sayaka Shimizu, Kakuya Niihata, Ken-ei Sada, Motoko Yanagita, Tsuguru Hatta, Masaomi Nangaku, Ritsuko Katafuchi, Yoshiro Fujita, Junji Koizumi, Shunzo Koizumi, Kenjiro Kimura, Shunichi Fukuhara, Yugo Shibagaki.
“Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method”
Clin Exp Nephrol. 2017;21:247–256. (Accepted: Apr 22, 2016)

(5) Hideki Yokoi, Motoko Yanagita.
“Targeting the fatty acid transport protein CD36, a class B scavenger receptor, in the treatment of renal disease”
Kidney Int . 2016;89:740–742. (Published: Mar 16, 2016)

(4) Hitoshi Nakashima, Mitsuhiro Kawano, Takako Saeki, Yoshifumi Ubara, Satoshi Hisano, Michio Nagata, Yoh Zen, Motoko Yanagita, Yutaka Yamaguchi, Shinichi Nishi, Takao Saito.
“Estimation of the number of histological Estimation of the number of histological diagnosis for IgG4-related kidney disease referred to the data obtained from the Japan Renal Biopsy Registry (J-RBR) questionnaire and cases reported in the Japanese Society of Nephrology Meetings”
Clin Exp Nephrol. 2017;21:97–103. (Accepted Mar 10, 2016)

(3) Takeshi Yamamoto, Yoshitsugu Takabatake, Tomonori Kimura, Atsushi Takahashi, Tomoko Namba, Jun Matsuda, Jun-ya Kaimori, Isao Matsui, Harumi Kitamura, Taiji Matsusaka, Fumio Niimura, Motoko Yanagita, Yoshitaka Isaka, Hiromi Rakugi.
“Time-dependent dysregulation of autophagy: Implications in aging and mitochondrial homeostasis in the kidney proximal tubule”
Autophagy. 2016;12:801–813. (Accepted: Feb 24, 2016)

(2) Takeshi Matsumoto, Kimihiko Murase, Ryo Tachikawa, Takuma Minami, Satoshi Hamada, Kiminobu Tanizawa, Morito Inouchi, Tomohiro Handa, Toru Oga, Motoko Yanagita, Michiaki Mishima, Kazuo Chin.
“Microalbuminuria in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome”
Ann Am Thorac Soc. 2016;13:917–925. (Accepted: Jan 24, 2016)

(1) Tatsuo Tsukamoto, Takayuki Matsubara, Yuka Akashi, Morihiro Kondo, Motoko Yanagita.
“Annual iron loss associated with hemodialysis”
Am J Nephrol. 2016;43:32–38. (Accepted: Jan 24, 2016)

2015年

(13) Takeshi Matsubara T, Osamu Ogawa, Motoko Yanagita.
“Physical finding of nutcracker phenomenon”
Kidney Int. 2013;83(2):335. (Published: Dec 16, 2015)

(12) Hideki Yokoi and Motoko Yanagita.
“Decrease of muscle volume in chronic kidney disease: the role of mitochondria in skeletal muscle”
Kidney Int. 2014; 85(6):1258–1260. (Published: Dec 16, 2015)

(11) Shota Ozawa, Shuko Ueda, Hiromi Imamura, Kiyoshi Mori, Katsuhiko Asanuma, Motoko Yanagita, Takahiko Nakagawa.
“Glycolysis, but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes”
Sci Rep. 2015;5:18575. (Accepted: Nov 23, 2015)

(10) Koji Takaori, Jin Nakamura, Shinya Yamamoto, Hirosuke Nakata, Yuki Sato, Masayuki Takase, Masaaki Nameta, Tadashi Yamamoto, Aris N. Economides, Kenji Kohno, Hironori Haga, Kumar Sharma, Motoko Yanagita.
“Severity and frequency of proximal tubule injury determines renal prognosis”
J Am Soc Nephrol. 2016;27(8):2393–2406. (Accepted: Nov 15, 2015)

(9) Shunsaku Nakagawa, Kumiko Nishihara, Hitomi Miyata, Haruka Shinke, Eri Tomita, Moto Kajiwara, Takeshi Matsubara, Noriyuki Iehara, Yoshinobu Igarashi, Hiroshi Yamada, Atsushi Fukatsu, Motoko Yanagita, Kazuo Matsubara, Satohiro Masuda.
“Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic Kidney disease”
PLoS One. 2015;10:e0136994. (Accepted: Aug 11, 2015)

(8) Hirotaka Imamaki, Akira Ishii, Hideki Yokoi, Masato Kasahara, Takashige Kuwabara, Keita P. Mori, Yukiko Kato, Takashi Kuwahara, Masugi Satoh, Kimihiko Nakatani, Yoshihiko Saito, Naohisa Tomosugi, Akira Sugawara, Kazuwa Nakao, Masashi Mukoyama, Motoko Yanagita, Kiyoshi Mori.
“Low serum neutrophil gelatinase-associated lipocalin level as a marker of malnutrition in maintenance hemodialysis patients”
PLoS One. 2015;10:e0132539. (Accepted: Jun 17, 2015)

(7) Shuko Ueda, Shota Ozawa, Kiyoshi Mori, Katsuhiko Asanuma, Motoko Yanagita, Shunya Uchida, Takahiko Nakagawa.
“ENOS deficiency causes podocyte injury with mitochondrial abnormality”
Free Radic Biol Med. 2015;87:181–192. (Accepted: Jun 8, 2015)

(6) Kenichi Koga, Hideki Yokoi, Kiyoshi Mori, Masato Kasahara, Takashige Kuwabara, Hirotaka Imamaki, Akira Ishii, Keita P. Mori, Yukiko Kato, Shoko Ohno, Naohiro Toda, Moin A. Saleem, Akira Sugawara, Kazuwa Nakao, Motoko Yanagita, Masashi Mukoyama.
“MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy”
Diabetologia. 2015;58(9):2169–2180. (Accepted: Apr 29, 2015)

(5) Takeshi Matsubara, Makoto Araki, Hideharu Abe, Otoya Ueda, Kou-ichi Jishage, Akira Mima, Chisato Goto, Tatsuya Tominaga, Masahiko Kinosaki, Seiji Kishi, Kojiro Nagai, Noriyuki Iehara, Naoshi Fukushima, Toru Kita, Hidenori Arai and Toshio Doi.
“Bone morphogenetic protein 4 and Smad1 mediate extracellular matrix production in the development of diabetic nephropathy”
Diabetes. 2015;64(8):2978–2990. (Accepted: Apr 12, 2015)

(4) Baku Nakakita, Haruta Mogami, Eiji Kondoh, Tatsuo Tsukamoto, Motoko Yanagita, Ikuo Konishi.
“Case of soluble fms-like tyrosine kinase 1 apheresis in severe pre-eclampsia developed at 15 weeks’ gestation”
J Obstet Gynaecol Res. 2015;41(10):1661-3. (Published: June 21, 2015)

(3) Shigeo Hara, Shunsuke Goto, Nozomu Kamiura, Akihiro Yoshimoto, Takayuki Naito, Naoko Imagawa, Yukihiro Imai, Motoko Yanagita, Shinichi Nishi, Tomoo Itoh.
“Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype”
Virchows Archiv. 2015;467(1):87–94. (Accepted: Mar 9, 2015)

(2) Yuichiro Kitai, Takeshi Matsubara, Motoko Yanagita.
“Onco-nephrology: current concepts and future perspectives”
Jpn J Clin Oncol. 2015; 45(7):617–628. (Accepted: Feb 17, 2015)

(1) Tomomi Endo, Jin Nakamura, Yuki Sato, Misako Asada, Ryo Yamada, Masayuki Takase, Koji Takaori, Akiko Oguchi, Taku Iguchi, Atsuko Y. Higashi, Tetsuya Ohbayashi, Tomoyuki Nakamura, Eri Muso, Takeshi Kimura, and Motoko Yanagita.
“Exploring the origin and limitations of kidney regeneration”
J Pathol. 2015;236(2):251–263. (Accepted: Feb 3, 2015)

2014年

(6) Shota Ozawa, Shuko Ueda, Ying Li, Kiyoshi Mori, Katsuhiko Asanuma, Motoko Yanagita, Takahiko Nakagawa.
“Fatty acid binding protein 3 as a potential mediator for diabetic nephropathy in eNOS deficient mouse”
Biochem Biophys Res Commun. 2014;454(4): 531–536. (Published: Oct 30, 2014)

(5) Ayami Tsuchimoto, Haruka Shinke, Miwa Uesugi, Mio Kikuchi, Emina Hashimoto, Tomoko Sato, Yasuhiro
Ogura, Koichiro Hata, Yasuhiro Fujimoto, Toshimi Kaido, Junji Kishimoto, Motoko Yanagita, Kazuo Matsubara, Shinji Uemoto, Satohiro Masuda.
“Urinary neutrophil gelatinase-associated lipocalin: A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients”
PLoS One. 2014;9:e110527. (Accepted: Sep 23, 2014)

(4) Matthias Mack, Motoko Yanagita.
“Origin of myofibroblasts and cellular events triggering fibrosis”
Kidney Int. 2015;87:297–307. (Accepted: Apr 10, 2014)

(3) Junya Kanda, Kiyoshi Mori, Hiroshi Kawabata, Takashige Kuwabara, Keita P. Mori, Hirotaka Imamaki, Masato Kasahara, Hideki Yokoi, Chisaki Mizumoto, Nils H. Thoennissen, H. Phillip Koeffler, Jonathan Barasch, Akifumi Takaori-Kondo, Masashi Mukoyama, Kazuwa Nakao.
“An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions”
Clin Exp Nephrol. 2015;19(1):99–106. (Accepted: Feb 17, 2014)

(2) Sachiko Yamada, Jin Nakamura, Misako Asada, Masayuki Takase, Taiji Matsusaka, Taku Iguchi, Ryo Yamada, Mari Tanaka, Atsuko Y Higashi, Tomohiko Okuda, Nariaki Asada,Atsushi Fukatsu, Hiroshi Kawachi, Daniel Graf, Eri Muso, Toru Kita, Takeshi Kimura, Ira Pastan, Aris N. Economides, and Motoko Yanagita.
“Twisted gastrulation, a BMP antagonist, exacerbates podocyte injury”
PLoS One. 2014;9:e89135. (Accepted: Jan 20, 2014)

(1) Takeshige Kuwabara, Kiyoshi Mori, Masato Kasahara, Hideki Yokoi, Hirotaka Imamaki, Akira Ishii, Kenichi Koga, Akira Sugawara, Shinji Yasuno, Kenji Ueshima, Takashi Morikawa, Yoshio Konishi, Masahito Imanishi, Akira Nishiyama, Kazuwa Nakao, Masashi Mukoyama.
“Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases”
PLoS One. 2014;9:e88942. (Accepted: Jan 14, 2014)

2013年

(10) Ryuichi Uetake, Takayuki Sakurai, Akiko Kamiyoshi, Yuka Ichikawa-Shindo, Hisaka Kawate, Yasuhiro Iesato, Takahiro Yoshizawa, Teruhide Koyama, Lei Yang, Yuichi Toriyama, Akihiro Yamauchi, Kyoko Igarashi, Megumu Tanaka, Takashige Kuwabara, Kiyoshi Mori, Motoko Yanagita, Masashi Mukoyama, Takayuki Shindo.
“Adrenomedullin-RAMP2 System Suppresses ER Stress-Induced Tubule Cell Death and Is Involved in Kidney”
PLoS One. 2014;9:e87667. (Accepted: Dec 29, 2013)

(9) Masato Kasahara, Takahiko Nakagawa, Hideki Yokoi, Takashige Kuwabara, Shinji Yasuno, Kiyoshi Mori, Masashi Mukoyama, Kenji Ueshima.
“Do statins play a role in renoprotection?”
Clin Exp Nephrol. 2014;18(2): 282–285. (Accepted: Dec 11, 2013)

(8) Takeshi Matsubara , Osamu Ogawa, Motoko Yanagita.
“The Authors Reply”
Kidney Int. 2013;84(6):1287. (Reply: Dec 01, 2013)

(7) Takeshige Kuwabara, Kiyoshi Mori, Masashi Mukoyama, Masato Kasahara, Hideki Yokoi, and Kazuwa Nakao.
“Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy”
Clin Exp Nephrol. 2014;18(4):584–592. (Accepted: Nov 28, 2013)

(6) Koji Takaori, Motoko Yanagita.
“Kidney regeneration and stem cells”
Anat Rec (Hoboken). 2014; 297: 129–136. (Accepted: Sep 13, 2013)

(5) Yuichirou Kitai, Neiko Ozasa, Takeshi Morimoto, Bingyuan Bao, Yutaka Furukawa,
Yoshihisa Nakagawa, Kazushige Kadota, Motoko Yanagita, Satoshi Shizuta, Takeshi Kimura.
“Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention”
Int J Cardiol. 2013;168(6): 5221–5228. (Accepted: Aug 3, 2013)

(4) Mayumi Tomita, Misako Asada, Nariaki Asada, Jin Nakamura, Akiko Oguchi, Atsuko Y Higashi, Shuichiro Endo, Elizabeth Robertson, Takeshi Kimura, Toru Kita, Aris N. Economides, Jordan Kreidberg, Motoko Yanagita.
“Bmp7 maintains undifferentiated kidney progenitor population and determines nephron numbers at birth”
PLoS One. 2013;8:e73554. (Accepted: July 29, 2013)

(3) Sato Y, Yanagita M.
“Renal anemia: from incurable to curable”
Am J Physiol Renal Physiol. 2013;305(9):F1239–F1248. (Accepted: July 19, 2013)

(2) Kenta Iijima, Noriyuki Okudaira, Masato Tamura, Akihiro Doi, Yoshikazu Saito, Mari Shimura, Motohito Goto, Akihiro Matsunaga, Yuki I Kawamura, Takeshi Otsubo, Taeko Dohi, Shigeki Hoshino, Shigeyuki Kano, Shotaro Hagiwara, Junko Tanuma, Hiroyuki Gatanaga, Masanori Baba, Taku Iguchi, Motoko Yanagita, Shinichi Oka, Tadashi Okamura, Yukihito Ishizaka.
“Viral protein R of human immunodeficiency virus type-1 induces retrotransposition of long interspersed element-1”
Retrovirology. 2013;10:83. (Accepted: July 18, 2013)

(1) Hiroshi Kawabata, Norimitsu Kadowaki, Momoko Nishikori, Toshio Kitawaki, Tadakazu Kondo, Takayuki Ishikawa, Hajime Yoshifuji, Noriyuki Yamakawa, Yoshitaka Imura, Tsuneyo Mimori, Yumi Matsumura, Yoshiki Miyachi, Takeshi Matsubara, Motoko Yanagita, Hironori Haga, Akifumi Takaori-Kondo.
“Clinical Features and Treatment of Multicentric Castleman’s Disease : A Retrospective Study of 21 Japanese Patients at a Single Institute”
J Clin Exp Hematop. 2013;53(1):69-77. (Accepted: Feb 08, 2013)

2012年

(7) Hitoshi Sugiyama , Hitoshi Yokoyama, Hiroshi Sato, Takao Saito, Yukimasa Kohda, Shinichi Nishi, Kazuhiko Tsuruya, Hideyasu Kiyomoto, Hiroyuki Iida, Tamaki Sasaki, Makoto Higuchi, Motoshi Hattori, Kazumasa Oka, Shoji Kagami, Tetsuya Kawamura, Tetsuro Takeda, Hiroshi Hataya, Yuichiro Fukasawa, Atsushi Fukatsu, Kunio Morozumi, Norishige Yoshikawa, Akira Shimizu, Hiroshi Kitamura, Yukio Yuzawa, Seiichi Matsuo, Yutaka Kiyohara, Kensuke Joh, Michio Nagata, Takashi Taguchi, Hirofumi Makino, Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry; Japanese Society of Nephrology.
“Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010”
Clin Exp Nephrol. 2013;17(2):155-73. (Accepted: Nov 18, 2012)

(6) Yuki Nakanishi, Hiroshi Seno, Ayumi Fukuoka, Taro Ueo, Yuichi Yamaga, Takahisa Maruno, Naoko Nakanishi, Keitaro Kanda, Hideyuki Komekado, Mayumi Kawada, Akihiro Isomura, Kenji Kawada, Yoshiharu Sakai, Motoko Yanagita, Ryoichiro Kageyama, Yoshiya Kawaguchi, Makoto M Taketo, Shin Yonehara, Tsutomu Chiba.
“Dclk1 distinguishes between tumor and normal stem cells in the intestine”
Nat Genet. 2013;45(1):98–103. (Accepted: Nov 5, 2012)

(5) Kentaro Suzuki, Yasuha Adachi, Tomokazu Numata, Shoko Nakada, Motoko Yanagita, Naomi Nakagata, Sylvia M. Evans, Daniel Graf, Aris Economides, Ryuma Haraguchi, Anne M. Moon, Gen Yamada.
“Reduced BMP signaling results in hindlimb fusion with lethal pelvic/urogenitalorgan aplasia: a new mouse model of sirenomelia”
Plos One. 2012;7(9):e43453. (Accepted: Jul 24, 2012)

(4) Hitoshi Yokoyama , Hitoshi Sugiyama, Hiroshi Sato, Takashi Taguchi, Michio Nagata, Seiichi Matsuo, Hirofumi Makino, Tsuyoshi Watanabe, Takao Saito, Yutaka Kiyohara, Shinichi Nishi, Hiroyuki Iida, Kunio Morozumi, Atsushi Fukatsu, Tamaki Sasaki, Kazuhiko Tsuruya, Yukimasa Kohda, Makoto Higuchi, Hideyasu Kiyomoto, Shin Goto, Motoshi Hattori, Hiroshi Hataya, Shoji Kagami, Norishige Yoshikawa, Yuichiro Fukasawa, Yoshihiko Ueda, Hiroshi Kitamura, Akira Shimizu, Kazumasa Oka, Naoki Nakagawa, Takafumi Ito, Shunya Uchida, Kengo Furuichi, Izaya Nakaya, Satoshi Umemura, Keiju Hiromura, Mitsuhiro Yoshimura, Nobuhito Hirawa, Takashi Shigematsu, Masafumi Fukagawa, Makoto Hiramatsu, Yoshio Terada, Osamu Uemura, Tetsuya Kawata, Akira Matsunaga, Aki Kuroki, Yasukiyo Mori, Koji Mitsuiki, Haruyoshi Yoshida, Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan.
“Renal Disease in the Elderly and the Very Elderly Japanese: Analysis of the Japan Renal Biopsy Registry (J-RBR)”
Clin Exp Nephrol. 2012;16(6):903-20. (Accepted July 12, 2012)

(3) Motoko Yanagita.
“Inhibitors/antagonists of the TGF-β system in kidney fibrosis”
Nephrol Dial Transplant. 2012;27(10):3686–3691. (Accepted: Jul 12, 2012)

(2) Hitomi Miyata, Kazuko Uno, Takahiko Ono, Masatomo Yashiro, Atsushi Fukatsu, Toru Kita, Takeshi Kimura, Eri Muso.
“Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome”
Ther Aper Dial. 2012;16(2):189–194. (Published: Feb 27, 2012)

(1) Jin Nakamura, Motoko Yanagita.
“Bmp modulators in kidney disease”
Discov Med. 2012;13(68):57–63. (Published: Jan 24, 2012)

2011年

(2) Nariaki Asada, Masayuki Takase, Jin Nakamura, Akiko Oguchi, Misako Asada, Norio Suzuki, Ken-ichi Yamamura, Narihito Nagoshi, Shinsuke Shibata, Tata Nageswara Rao, Hans Joerg Fehling, Atsushi Fukatsu, Naoko Minegishi, Toru Kita, Takeshi Kimura, Hideyuki Okano, Masayuki Yamamoto, Motoko Yanagita.
“Dysfunction of fibroblasts of extra-renal origin underlies renal fibrosis and renal anemia in mice”
J Clin Invest. 2011;121(10): 3981–3990. (Accepted: Jul 26, 2011)

(1) Hiroshi Kanamori, Kojiro Nagai, Takeshi Matsubara, Akira Mima, Motoko Yanagita, Noriyuki Iehara, Hajime Takechi, Keiichi Fujimaki, Kazumasa Usami, Atsushi Fukatsu, Toru Kita, Kozo Matsubayashi, Hidenori Arai.
“Comparison of the psychosocial quality of life in hemodialysis patients between the elderly and non-elderly using a visual analogue scale: the importance
of appetite and depressive mood”
Geriatr Gerontol Int. 2012;12(1):65–71. (Accepted: Jun 21, 2011)

2010年

(1) Motoko Yanagita.
“Antagonists of bone morphogenetic proteins in kidney disease”
Curr Opin Invest Drugs. 2010;11(3):315–322.

2009年

(3) Mari Tanaka, Misako Asada, Atsuko Y. Higashi, Jin Nakamura, Akiko Oguchi, Mayumi Tomita, Sachiko Yamada, Nariaki Asada, Masayuki Takase, Tomohiko Okuda, Hiroshi Kawachi, Aris N. Economides, Elizabeth Robertson, Satoru Takahashi, Takeshi Sakurai, Roel Goldschmeding, Eri Muso, Atsushi Fukatsu, Toru Kita, Motoko Yanagita.
“Loss of the BMP antagonist, USAG-1 ameliorates disease in a mouse model of progressive hereditary kidney disease Alport syndrome”
J Clin Invest. 2010;120(3):768–777. (Accepted: Nov 24, 2009)

(2) Kentaro Suzuki, Aris Economides, Motoko Yanagita, Daniel Graf, Gen Yamada.
“New horizons at the caudal embryos: coordinated urogenital/reproductive organ formation by growth factor signaling”
Curr Opin Genet Dev. 2009;19(5):491–496. (Published: Sep 16, 2009)

(1) Atsuko Yoshioka Higashi, Tomokatsu Ikawa, Masamichi Muramatsu, Aris N. Economides, Akira Niwa, Tomohiko Okuda, Andrew J. Murphy, Jose Rojas, Toshio Heike, Tatsutoshi Nakahata, Hiroshi Kawamoto, Toru Kita, Motoko Yanagita.
Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
J Immunol. 2009;182(9):5633–5640. (Accepted: Feb 26, 2009)

2008年

(2) Motoko Yanagita.
“BMP modulators regulate the function of BMP during body patterning and disease progression”
Biofactors. 2009;35(2):113–119. (Accepted: Nov 29. 2008)

(1) Akiko Murashima-Suginami, Katsu Takahashi, Tomoko Sakata, Hiroko Tsukamoto, Manabu Sugai, Motoko Yanagita, Akira Shimizu, Takeshi Sakurai, Harold C. Slavkin, Kazuhisa Bessho.
“Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse”
Biochem Biophys Res Commun. 2008;369(4):1012-6. (Available online Mar 7, 2008)

2007年

(4) Akira Mima, Kimiyoshi Ichida, Takeshi Matsubara, Hiroshi Kanamori, Emi Inui, Misa Tanaka, Yumi Manabe, Noriyuki Iehara, Yoshinori Tanaka, Motoko Yanagita, Atsuko Yoshioka, Hidenori Arai, Masashi Kawamura, Katsumasa Usami, Tatsuo Hosoya, Toru Kita, Atsushi Fukatsu.
“Acute renal failure after exercise in a Japanese sumo wrestler with renal hypouricemia”
Am J Med Sci. 2008;336(6):512-4. (Accepted Nov 28, 2007)

(3) Motoko Yanagita.
“Balance between bone morphogenetic proteins and their antagonists in kidney injury”
Ther Apher Dial. 2007;11 Suppl 1:S38-43. (Published: Oct 29, 2007)

(2) Mari Tanaka, Shuichiro Endo, Tomohiko Okuda, Aris N. Economides, David M. Valenzuela, Andrew J. Murphy, Elizabeth Robertson, Takeshi Sakurai, Atsushi Fukatsu, George D. Yancopoulos, Toru Kita, Motoko Yanagita.
“Expression of BMP-7 and USAG-1 (a BMP antagonist) in kidney development and injury”
Kidney Int. 2008;73(2):181–191. (Accepted: Aug 14, 2007)

(1) Akiko Murashima-Suginami, Katsu Takahashi, Tomohiro Kawabata, Tomoko Sakata, Hiroko Tsukamoto, Manabu Sugai, Motoko Yanagita, Akira Shimizu, Takeshi Sakurai, Harold C. Slavkin, Kazuhisa Bessho.
“Rudiment incisors survive and erupt as supernumerary teeth as a result of USAG-1 abrogation”
Biochem Biophys Res Commun. 2007;359(3):549-55. (Available online: May 30, 2007)

2006年

(2) Motoko Yanagita.
“Modulator of bone morphogenetic protein activity in the progression of kidney diseases”
Kidney Int. 2006;70(6):989–993. (Accepted: Jun 2, 2006)

(1) Tateo Sawabu, Hiroshi Seno, Tomoko Kawashima, Akihisa Fukuda, Yoshito Uenoyama, Mayumi Kawada, Naoki Kanda, Akira Sekikawa, Hirokazu Fukui, Motoko Yanagita, Hiroshi Yoshibayashi, Seiji Satoh, Yoshiharu Sakai, Toru Nakano, Tsutomu Chiba.
“Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway”
Mol Carcinog. 2007;46(2):155-64. (Accepted: Feb 13, 2006)

2005年

(3) Motoko Yanagita, Tomohiko Okuda, Shuichiro Endo, Mari Tanaka, Katsu Takahashi, Fumihiro Sugiyama, Satoshi Kunita, Satoru Takahashi, Atsushi Fukatsu, Masashi Yanagisawa, Toru Kita, Takeshi Sakurai.
“Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury”
J Clin Invest. 2006;116(1):70–79. (Accepted: Oct 11, 2005)

(2) Motoko Yanagita.
“BMP antagonists: their roles in development and involvement in pathophysiology”
Cytokine Growth Factor Rev. 2005;16(3):309–317. (Published: Jun 13, 2005)

(1) Kojiro Nagai, Takeshi Matsubara, Akira Mima, Eriko Sumi, Hiroshi Kanamori, Noriaki Iehara, Atsushi Fukatsu, Motoko Yanagita, Toru Nakano, Yoshikazu Ishimoto, Toru Kita, Toshio Doi, Hidenori Arai.
“Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy”
Kidney Int. 2005;68(2):552-61. (Accepted: Feb 28, 2005)

2004年

(3) Motoko Yanagita.
“Gas6, warfarin, and kidney diseases”
Clin Exp Nephrol. 2004;8(4):304-9. (Published: December, 2004)

(2) Motoko Yanagita.
“The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology”
Curr Opin Nephrol Hypertens. 2004;13(4):465–470. (Published: Jul 1, 2004)

(1) Motoko Yanagita, Masako Oka, Tetsuro Watabe, Haruhisa Iguchi, Atsushi Niida, Satoru Takahashi, Tetsu Akiyama, Kohei Miyazono, Masashi Yanagisawa, TakeshiSakura.
“USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney”
Biochem Biophys Res Commun. 2004;316(2):490–500. (Published: Feb 26, 2004)

2003年

(1) Kojiro Nagai, Hidenori Arai, Motoko Yanagita, Takeo Matsubara, Hirokazu Kanamori, Toru Nakano, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Toshio Doi.
“Growth Arrest-specific Gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy.”
J Biol Chem. 2003;278(20):18229-34.

2002年

(1) Motoko Yanagita, Yoshikazu Ishimoto, Hidenori Arai, Kojiro Nagai, Tsuyoshi Ito, Toru Nakano, David Salant, Atsushi Fukatsu, Toshio Doi, Toru Kita.
“Essential role of Gas6 for glomerular injury in nephrotoxic nephritis.”
J Clin Invest. 2002;110(2):239-46.

2001年

(2) Motoko Yanagita, Hidenori Arai, Toru Nakano, Kazumasa Ohashi, Kensaku Mizuno, Brian Varnum, Atsushi Fukatsu, Toshio Doi, Toru Kita.
“Gas6 induces mesangial cell proliferation via latent transcription factor STAT3”
J Biol Chem. 2001;276(45);42364-42369.

(1) Motoko Yanagita, Hhttps://linkinghub.elsevier.com/retrieve/pii/S0002-9440(10)64093-Xidenori Arai, Kenji Ishii, Toru Nakano, Kazumasa Ohashi, Kensaku Mizuno, Brian Varnum, Atsushi Fukatsu, Toshio Doi, Toru Kita.
“Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis”
Am J Pathol . 2001;158(4);1423-32.

1999年

(1) Motoko Yanagita, Kenji Ishii, Harunobu Ozaki, Hidenori Arai, Kazumasa Ohashi, Kensaku Mizuno, Toru Nakano, Toru Kita and Toshio Doi.
“Mechanism of inhibitory effect of warfarin on mesangial cell proliferation”
J Am Soc Nephrol . 1999;10(12);2503-9.

1998年

(3) Hiroya Takeoka, Noriyuki Iehara, Motoko Uematsu-Yanagita, Hideharu Abe, Masaaki Sunamoto, Yoshihiko Yamada, Toru Kita, Toshio Doi.
“A multifunctional transcription factor (A1p145) regulates the smooth muscle phenotype in mesangial cells”
Biochem Biophys Res Commun Thromb Haemost. 1998; 252(2): 290-5.

(2) Akihiko Hamasaki, Kenji Ishii, Kyoichi Yamaguchi, Masaaki Sunamoto, Harunobu Ozaki, Motoko Yanagita, Yoshio Wakatsuki, Hisanori Horiuchi, Yoshikatsu Nakahata, Toru Kita.
“Steroid hormone-responsive secondary factor X deficiency”
Thromb Haemost. 1998;80(6):1032-3.

(1) Junko Ohata, Hiroshi Akasaka, Susumu Kobayashi, Motoko Yanagita, Kazuro Kanatsu, Michihiko Uchida.
“A case of B cell malignant lymphoma with positive adult T cell leukemia antibody coexistent with idiopathic thrombocytopenic purpura”
Internal Med. 1998;81(4):776-8.

1997年

(1) Motoko Uematsu-Yanagita, Daisuke Inoue, Hiroyuki Koshiyama, Takashi Akamizu.
“Familial clustering of thyroid stimulation-blocking antibody”
Arch Intern Med. 1997;157(4):462-4.

1996年

(1) Motoko Uematsu-Yanagita, Mikimaro Cho, Yasuhiro Hakamata, Makoto Tanaka, Kenji Ishii, Noriaki Kume, Hiroshi Ochi, Yoshio Wakatsuki, Masayuki Yokode, Motonobu Murakami, Hideyuki Yoshioka, Toshio Doi, Toru Kita.
“Microscopic Polyarteritis during Polymyalgia Remission”
Am J Kidney Dis. 1996;28(2):289-91.

1995年

(1) Motoko Uematsu, Hiroshi Ochi, Yukihiko Ueda, Yasuhito Hakamata, Masayuki Yokode, Yataro Yoshida, Toru Kita.
“Coexistent myelodysplastic syndrome and non-Hodgkin lymphoma. Report of a case and review of the literature”
Int J Hematol. 1995;62(1):45-51.

発表論文(和文)

2019年

(7) 【佐藤 有紀, 柳田 素子】
「腎臓と線維化」
BIO Clinica 34(12) Page 1192–1196(2019.10)

(6) 【佐藤 有紀, 柳田 素子】
「尿細管間質障害の進展機序」
腎と透析 増大号 87(2) Page 178–182(2019.08)

(5) 【鳥生 直哉, 佐藤 有紀, 柳田 素子】
「腎臓のアンチエイジング」
医学のあゆみBooks アンチエイジング診療 23のエッセンス(医歯薬出版)Page 21–27(2019.06)

(4) 【好川 貴久, 佐藤 有紀, 柳田 素子】
「老化と線維化」
アンチ・エイジング医学 15(3) Page 324–329(2019.06)

(3) 【矢野 景子, 佐藤 有紀, 柳田 素子】
「AKIとCKDのクロストーク」
臨牀透析 35(6) Page 71–75(2019.06)

(2) 【山本 恵則, 佐藤 有紀, 柳田 素子】
「難治性腎疾患に対するミトコンドリア・メディスン」
腎臓内科・泌尿器科 9(5) Page 491–495(2019.05)

(1) 【比良野 圭太, 佐藤 有紀, 柳田 素子】
「エビデンスに基づく腎機能進展を抑制するための治療」
アンチ・エイジング医学 15(1) Page 62–70(2019.02)

2018年

(11) 【高橋 昌宏, 佐藤 有紀, 柳田 素子】
「老化と代謝からみた「治る」と「治らない」の境界線」
腎とフリーラジカル研究会誌 vol.13 Page 32–38(2018.11)

(10) 【大野 絵里菜, 遠藤 修一郎, 佐藤 憲明, 高橋 昌宏, 松原 雄, 横井 秀基, 柳田 素子】
「ステロイド不応性の蛋白尿を伴う進行性腎機能障害の1例」
臨牀透析 34(10) Page 1258–1265(2018.09)

(9) 【佐藤 有紀, 柳田 素子】
「男性ホルモンと腎臓病」
腎臓内科・泌尿器科 8(2) Page 145–149(2018.08)

(8) 【松原 雄, 柳田 素子】
「坑がん薬と急性腎障害(特集 腎疾患領域における薬剤管理 今注目されるポイント)」
日本内科学会雑誌 107(5) Page 865–871(2018.05)

(7) 【森 慶太, 柳田 素子】
「腎臓の線維化,腎性貧血のメカニズムとSGLT2阻害薬」
内分泌・糖尿病・代謝内科 46(4) Page 305–309(2018.04)

(6) 【好川 貴久, 佐藤 有紀, 柳田 素子】
「腎線維化を担う細胞とその多彩な機能(特集 線維化と腎泌尿器疾患)」
腎臓内科・泌尿器科 7(4) Page 335–340(2018.04)

(5) 【高折 光司, 柳田 素子】
「AKIとCKDのクロストーク」
日本透析医学会雑誌51巻2号 Page 159–165(2018.02)

(4) 【森 潔, 森 慶太, 柳田 素子】
「AKIバイオマーカーの出現機序(特集 急性腎障害(AKI)の最新知見を凝縮する)」
腎・高血圧の最新治療 7(1) Page 17–24(2018.01)

(3) 【森 慶太, 森 潔】
「新視点 : 腎臓の濾過・再吸収からみた糖尿病性腎症におけるアルブミン尿」(TOPICS 腎臓内科学)
医学のあゆみ 264(3) Page 255–256 (2018.01)

(2) 【佐藤 有紀】
「虚血性AKIについて」
腎・高血圧の最新治療 7(1) Page 30–35(2018.01)

(1) 【小口 亜希子, 佐藤 有紀, 柳田 素子】
「腎線維化の機序と治療」
Pharma Medica 36(1) Page 41–44 (2018.01)

2017年

(10) 【松原 雄, 柳田 素子】
「悪性腫瘍(特集 腎不全合併症治療のupdate)」
腎臓内科・泌尿器科5巻4号 Page 349–355(2017.11)

(9) 【松原 雄, 柳田 素子】
「末期腎不全患者におけるがん診察の実態(特集 Onco-Nephrology(癌と腎臓病))」
医学のあゆみ262巻11号 Page 1027–1031(2017.09)

(8) 【佐藤 有紀, 柳田 素子】
「高齢者のAKIはなぜ治りにくいのか?」
腎と透析 増大号 83巻3号 Page 499–502(2017.09)

(7) 【松原 雄, 柳田 素子】
「Overview(特集 Onco-nephrology)」
日本腎臓学会誌59巻5号 Page 590–593(2017.07)

(6) 【佐藤 有紀】
「加齢個体における腎三次リンパ組織形成メカニズムの解明」
アンチ・エイジング医学 13巻3号 Page 366–371(2017.06)

(6) 【北井 悠一朗, 柳田 素子】
「性ホルモンと腎臓病(特集 腎泌尿器の女性・新生児医学)?(妊娠と腎泌尿器疾患)」
腎臓内科・泌尿器科5巻4号 Page 349–355(2017.04)

(5) 【石井 輝, 横井 秀基, 森 潔, 森 慶太, 古賀 健一, 柳田 素子】
「糖尿病腎症は糸球体or尿細管障害のどちらから始まるか?(特集 糖尿病患者の腎機能障害)」
内分泌・糖尿病・代謝内科44巻3号 Page 215–221(2017.03)

(4) 【柳田 素子, 前田 健一郎】
「編集長VISITING(400)学術的新領域Onco-nephrology診療・研究面で薬剤師とも連携」
医薬ジャーナル53巻3号 Page 164–168(2017.03)

(3) 【姜 伶奈, 佐藤 有紀, 柳田 素子】
「性差と腎臓病」
腎臓 39巻(通巻114号) Page 10–14(2017.03)

(2) 【石原 仁毅, 福間 真悟, 柳田 素子】
「Mendelian readomization」
腎臓内科・泌尿器科5巻1号 Page 77–81(2017.01)

(1) 【近藤 尚哉, 武藤 学, 福原 俊一, 柳田 素子】
「慢性透析患者におけるがん薬物療法の実態」
日本透析医学会雑誌50巻1号 Page 64–65(2017.01)

2016年

(5)【山本 恵則, 佐藤 有紀, 柳田 素子】
「最新のCKDのバイオマーカー(特集 慢性腎臓病(CKD)治療の最前線:生活習慣病への新たなアプローチ)–(CKD診断・治療のUp-to-Date)」
最新醫學71巻12号 Page 2467–2472(2016.12)

(4)【松原 雄, 柳田 素子】
「抗がん薬と急性腎障害(特集 Onco-nephrology:腫瘍学と腎臓病学の融合)」
医薬ジャーナル52巻9号 Page 69–74(2016.09)

(3)【北井 悠一朗, 柳田 素子】
「Onco-nephrologyとは(特集 Onco-nephrology:腫瘍学と腎臓病学の融合)」
医薬ジャーナル52巻9号 Page 69–74(2016.09)

(2)【近藤 麻紀子, 柳田 素子】
「CKDの発症と進展(特集 急性腎障害(AKI)と慢性腎臓病(CKD))–(CKD)」
臨牀と研究93巻7号 Page 934–937(2016.07)

(1)【姜 伶奈, 柳田 素子】
「慢性腎臓病における性差(特集Men’s Health)」
日本医師会雑誌145巻2号 Page 1243–246(2016.05)

2015年

(1)【佐藤 有紀, 柳田 素子】
「腎臓における炎症と線維化 」
細胞 47巻4号 Page 168–171 (2015.04)

(2)【比良野 圭太, 柳田 素子】
「主要な疾患と先制医療 遺伝素因、環境因子、発症前診断の可能性、予防法代謝・内分泌疾患 腎疾患」
実験医学 (0288-5514)33巻7号 Page 1071–1077 (2015.05)

(3)【松原 雄, 比良野 圭太, 柳田 素子】
「Onco-Nephrology なぜいま注目を集めているのか」
臨床泌尿器科 (0385-2393)69巻7号 Page 534–539 (2015.06)

(4)【山田 博之, 塚本 達雄, 柳田 素子】
「ハイリスク・特殊血液浄化 overview」
腎臓内科・泌尿器科 (2188-9147)1巻6号 Page 523–527 (2015.06)

(5)【横井 秀基, 柳田 素子】
「トランスレーショナルリサーチへの誘い(第1回) トランスレーショナルリサーチとは何か?」
尿酸と血糖 (2188-952X)1巻2号 Page 80–82 (2015.07)

(6)【北井 悠一朗, 柳田 素子】
「テストステロンとアンチエイジング テストステロンと腎機能」
腎臓内科・泌尿器科 (2188-9147)2巻1号 Page 45–49 (2015.07)

(7)【塚本 達雄, 山田 敦美, 飯田 恵, 安馬 雅範, 柳田 素子】
「血液浄化器取り違え事故3年後における再発防止策進行状況と問題点」
日本急性血液浄化学会雑誌 (2185-1085)6巻1号 Page 3–9 (2015.06)

(8)【金子 惠一, 柳田 素子】
「トピックス 貧血治療の新しい流れ EPO産生細胞の機能回復を目指した治療」
腎と透析 (0385-2156)79巻1号 Page 128–133 (2015.07)

(9)【山本 伸也, 柳田 素子】
「腎臓におけるエネルギー産生と消費」
腎臓内科・泌尿器科 (2188-9147)2巻2号 Page 217–225 (2015.08)

(10)【森 潔, 土田 潤一, 桒原 孝成, 向山 政志, 横井 秀基, 笠原 正登, 柳田 素子】
「循環器疾患における各種バイオマーカーの意義 TLR4と関連因子」
Heart View (1342-6591)19巻12号 Page 168–171 (2015.11)

(11)【小口 綾貴子, 横井 秀基, 今牧 博貴, 桒原 孝成, 清水 葉子, 笠原 正登, 向山 政志, 塚本 達雄, 柳田 素子】
「腹膜透析中に急激に心嚢水・胸水を発症し、血液透析移行後著明に改善した心外膜炎の1例」
腎と透析 (0385-2156)79巻別冊 腹膜透析2015 Page 165–166 (2015.10)

(12)【佐藤 有紀, 柳田 素子】
「腎線維化の原因細胞と成因」日本腎臓学会誌(0385-2385) 57巻7号 Page 1187–1192 (2015.10)

(13)【高折 光司, 柳田 素子】
「腎臓病治療の将来:basic scienceからonconephrologyまで」
麻酔64(増刊)Page S1–9 (2015.11)

(14)【山田 博之, 塚本 達雄, 宮田 仁美, 秦 浩一郎, 岡島 英明, 上本 伸二, 柳田 素子】
「消化器肝臓疾患とアフェレシス療法 劇症肝炎、肝移植へのアフェレシス療法」
腎と透析 (0385-2156)78巻2号 Page 218–221 (2015.02)

(15)【森 潔, 横井 秀基, 笠原 正登, 向山 政志, 柳田 素子】
「ポドサイトに発現する受容体」
腎と透析 (0385-2156)78巻3号 Page 373–379 (2015.03)

(16)【比良野 圭太, 柳田 素子】特集Onconephrology-腎臓病とがんの深いかかわり-
「なぜ今Onconephrologyが必要か:現状と今後の展開」腎臓内科・泌尿器科 1巻1号
1–9, 科学評論社 2015.

(17)【松原 雄】特集Onconephrology-腎臓病とがんの深いかかわり-
「腎不全患者のがん治療 2)腎不全患者におけるがん診療の病態」腎臓内科・泌尿器科 1巻1号
61–67, 科学評論社 2015.

2014年

(1)【中田 紘介, 柳田 素子】
「腎疾患とEPO産生細胞」
日本内科学会雑誌 103(1) Page 160–165 (2014)

(2)【森 潔, 桒原 孝成, 横井 秀基, 笠原 正登, 向山 政志, 柳田 素子】
「急性腎障害のバイオマーカー動向」
臨床化学 43(1) Page 5–8 (2014)

(3)【金子 惠一, 柳田 素子】
「腎間質細胞とCKD」
Medical Science Digest 40(4) Page 162–165 (2014)

(4)【佐藤 有紀, 柳田 素子】
「腎性貧血と腎機能低下はどこまで治るのか」
腎と透析 76巻2号(2月号) Page 252–255 (2014)

(5)【佐藤 有紀, 柳田 素子】
「胎内環境と慢性疾患」
Medicina 51(10) Page 1984–1986 (2014)

(6)【佐藤 有紀, 柳田 素子】
「線維化と腎性貧血を繋ぐ病態の解明」
全人力・科学力・透析力に基づく透析医学 第6章 Page 351–354 (2014)

(7)【佐藤 有紀, 柳田 素子】
「研究施設紹介:京都大学大学院医学研究科腎臓内科学講座」
Nephrology Frontier 13 (1) Page 92–95, (2014)

(8)【山本 伸也, 柳田 素子】
「Bardoxolone methylに学ぶCKDの可逆性」
医学のあゆみ, 249(7), Page 627–629, (2014)

(9)【佐藤 有紀, 柳田 素子】
「腎線維化の機序と併存する病態との関連」
医学のあゆみ, 249(9), Page 953–958 (2014)

(10)【植村 忠廣, 山田 博之, 宮田 仁美, 塚本 達雄, 柳田 素子, 冨山 浩司, 岡島 英明, 海道 利実, 上本 伸二】
「肝移植におけるICU管理」
ICUとCCU 38(2) Page 91–95 (2014)

(11)【森 慶太, 笠原 正登】
「hANP(カルペリチド)」
循環器内科 75(3) Page 280–287 (2014)

2013年

(1)【松原 雄, 柳田 素子】
「腎疾患に対する薬剤の使用方法 虚血性腎症」
腎と透析 74巻増刊 Page 254–256 (2013)

(2)【塚本 達雄】
「透析患者に対する薬の使い方 対症療法 女性化乳房」
腎と透析 74巻増刊 Page 427–430 (2013)

(3)【塚本 達雄, 柳田 素子】
「持続血液浄化療法施行中の医療器具取り違えによる肝移植後患者死亡-事例報告と再発防止策-」
日本急性血液浄化学会雑誌 4(2) Page 148–153 (2013)

(4)【佐藤 有紀, 柳田 素子】
「CKDにおける貧血と臓器保護」
腎と透析9月号, Page 319–322 (2013)

(5)【中村 仁, 柳田 素子】
「腎線維化のメカニズム」
Annual Review 腎臓2013, Page 75–79, (2013)

(6)【佐藤 有紀, 柳田 素子】
「慢性腎臓病と慢性炎症」
慢性炎症と生活習慣病 第II部, Page 91–100, (2013)

(7)【佐藤 有紀, 柳田 素子】
「腎線維化」
Current Therapy 31(6), Page 8–12 (2013)

2012年

(1)【柳田 素子】
「尿細管性アシドーシスとその他の尿細管疾患」
今日の治療指針2012 医学書院 2012

(2)【高折 光司, 柳田 素子】
「基礎研究の治験を腎臓病診療に生かす」
Medicina 49(5), Page 904–906 (2012)

(3)【佐藤 有紀, 柳田 素子】
「Alport症候群」
臨床雑誌 内科 109(6), Page 1366–1367 (2012)

(4)【高瀬 昌幸, 柳田 素子】
「線維化と腎性貧血を制御する」
細胞 44(5), Page 208–211 (2012)

(5)【高折 光司, 柳田 素子】
「腎線維化の病態解明と治療戦略」
医薬ジャーナル 48(11), Page 2571–2574 (2012)

(6)【高折 光司, 柳田 素子】
「糖尿病性腎症の治療戦略」BIO Clinica, 27(14), Page 1322–1326 (2012)

2011年

(1)【松原 雄, 家原 典之, 深津 敦司】電解質異常(低カリウム血症, 高カルシウム血症)(特集 腎障害をきたす全身性疾患‐最近の進歩)
日本内科学会雑誌, 100(5), Page 1313–1318 (2011)

(2)【長尾 和浩, 西岡 敬祐, 前田 利彦, 田中 麻理, 遠藤 修一郎,
宮田 仁美, 松原 雄, 家原 典之, 深津 敦司】不明熱の原因としてgraft intolerance syndrome(GIS)が強く疑われた移植腎機能廃絶後の腹膜透析患者の一例
腎と透析 71巻別冊 腹膜透析, Page 125–126 (2011)

(3)【高折 光司, 柳田 素子】
「USAG-1, BMPアンタゴニストと腎疾患」
感染・炎症・免疫, 41(3), Page 239–241 (2011)

(4)【佐藤 有紀, 柳田 素子】
「慢性腎臓病における糸球体・尿細管クロストーク」
BIO Clinica, 27(1), Page 95-99 (2011)

(5)【高瀬 昌幸, 柳田 素子】
「線維化を起こす細胞群と腎性貧血」
医学のあゆみ, 240(4), Page 288–292 (2011)

Book Chapter

1 Takeshi Yokoo and Motoko Yanagita.
“Stem cell therapy against oxidative stress and hypoxia.”(Book chapter)
“Oxidative Stress and Hypoxia in Renal Disorders”,
edited by Kai-Uwe
Eckardt and Toshio Miyata, published from The Human Press/Springer Science, 2011.

2 Motoko Yanagita
“BMP antagonists and kidney.” (Book chapter)
“Bone Morphogenetic Protein:
From Local to Systemic Therapeutics”,
edited by Vukicevic Slobodan and Kuber Sampath, published from Birkhauser, Springer Verlag, 2008.

3 Motoko Yanagita
“Uterine Sensitization
Associated Gene-1 (USAG-1): A Bone Morphogenetic Protein Antagonist in the Kidney.” (Book chapter)
“TRANSFORMING GROWTH FACTOR-β IN CANCER THERAPY”,
edited by Sonia B. Jakowlew, published from